Zepbound (tirzepatide) is a relatively new glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) weekly subcutaneous prescription medication for people with obesity or overweight
The top six groups of psychiatric AEs with the highest number of reports were insomnia ( n = 1,198, 11.70%), anxiety ( n = 1,131, 11.04%), nervousness ( n = 941, 9.19%), depression ( n = 770, 7.52%), stress ( n = 770, 7.52%), and confusional state ( n = 689, 6.73%)
What the premium pays for is the bit the medication cant do on its own: A named, qualified clinician or dietitian who knows your history and isnt a rotating call centre Support building healthy habits to prevent weight regain, not just the prescription Support managing side effects so you dont end up reducing your dose unnecessarily A tapering protocol for when you eventually come off the medication, or maintain at a lower dose, designed to protect against regain Whether thats worth 50-150 a month depends on whether youd build those habits and stick to the plan without support
Kimberly Jackson explained how Ivy Rxs compounded medications worked just as effectively as branded options, without the crushing price tag
